ONCOSEC MEDICAL Inc financial data

Symbol
ONCSQ on OTC
Industry
Pharmaceutical Preparations
Location
820 Bear Tavern Road, Ewing, NJ
State of incorporation
NV
Fiscal year end
July 31
Former names
NetVentory Solutions, Inc. (to 2/4/2011)
Latest financial report
10-Q - Q4 2022 - Mar 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 202 % -69.3%
Debt-to-equity 361 % +627%
Return On Assets -161 % -96.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.97M shares -92.4%
Common Stock, Shares, Outstanding 2.97M shares -92.4%
Common Stock, Value, Issued 297 USD -92.5%
Weighted Average Number of Shares Outstanding, Basic 2.59M shares +44.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 21.8M USD -24.5%
General and Administrative Expense 10.9M USD -26.5%
Operating Income (Loss) -32.7M USD +25.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.7M USD +24.6%
Income Tax Expense (Benefit) 2.95K USD 0%
Net Income (Loss) Attributable to Parent -29.4M USD +28.2%
Earnings Per Share, Basic 3.03 USD/shares +52.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.1M USD -67.9%
Assets, Current 6.44M USD -76.9%
Property, Plant and Equipment, Net 902K USD -15.8%
Operating Lease, Right-of-Use Asset 622K USD -87.9%
Other Assets, Noncurrent 562K USD +6.55%
Assets 8.87M USD -74.7%
Employee-related Liabilities, Current 1.2M USD +106%
Accrued Liabilities, Current 1.2M USD +106%
Liabilities, Current 7.23M USD +29.8%
Operating Lease, Liability, Noncurrent 214K USD -95.5%
Liabilities 14.4M USD -6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 154K USD -11.6%
Retained Earnings (Accumulated Deficit) -301M USD -10.8%
Stockholders' Equity Attributable to Parent -2.5M USD -113%
Liabilities and Equity 8.87M USD -74.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.13M USD +37.9%
Net Cash Provided by (Used in) Financing Activities -343K USD +6.61%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.97M shares -92.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.57M USD +35.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.1K USD +37.7%
Deferred Tax Assets, Valuation Allowance 72.2M USD +14%
Deferred Tax Assets, Gross 72.2M USD +14%
Operating Lease, Liability 1.17M USD -79.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.4M USD +27.4%
Lessee, Operating Lease, Liability, to be Paid 1.25M USD -82.6%
Property, Plant and Equipment, Gross 2.54M USD +0.24%
Operating Lease, Liability, Current 958K USD -7.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 122K USD -92.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 342K USD -78.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 78K USD -94.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.43M USD -5.53%
Deferred Tax Assets, Operating Loss Carryforwards 63.8M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 241K USD -84.3%
Operating Lease, Payments 1.55M USD +2.12%
Amortization of Intangible Assets 70K USD +1.45%
Depreciation, Depletion and Amortization 62.4K USD -2.52%
Interest Expense 52.1K USD +183%